admin_labo

admin_labo

Increasing utrophin expression in DMD using CRISPR-Cas9

One therapeutic approach for Duchenne muscular dystrophy (DMD) involves increasing the expression of utrophin to compensate for the absence of dystrophin, with which it shares a high degree of homology. A team at Généthon used the CRISPR-Cas9 system to generate…

ERN EURO-NMD webinar, 7 May : Prof. Mathilde Duchesne (France)

Episode 4 – Infectious and Neoplastic Neuropathies (in EURO-NMD Neuropathology Webinar Series) Thursday 7 May 2026 – 16:00-17:00 Paris time Speaker: Prof. Mathilde Duchesne (CHU Limoges, France) Moderators: Dr. Matteo Garibaldi (Sant’Andrea Hospital of Sapienza University of Rome, Italy), Prof. Joachim Weis(Director,…